rs199472685
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000218.3(KCNQ1):āc.401T>Cā(p.Leu134Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461800Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727202
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:2
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 134 of the KCNQ1 protein (p.Leu134Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of KCNQ1-related conditions (PMID: 19716085). ClinVar contains an entry for this variant (Variation ID: 67070). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 29532034, 30571187). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Pathogenic:1
This missense change is denoted Leu134Pro (aka L134P) at the protein level and c.401 T>C at the cDNA level. The Leu134Pro mutation in the KCNQ1 gene has been previously published in a single individual referred for LQTS testing and was absent from more than 2600 control alleles (Kapplinger et al., 2009). Leu134Pro results in a non-conservative amino acid substitution of a non-polar Leucine with a non-polar, sterically-constrained Proline at a residue that is located in the highly conserved transmembrane domain of the protein. In silico analysis predicts Leu134Pro is probably damaging to protein structure/function (Adzhubei IA et al., 2010, Schwarz JM et al., 2010). Nearby mutations (Ile132Leu, Val133Ile, Cys136Phe, Leu137Phe) have been reported in association with LQTS further supporting the functional importance of this region of the protein. In addition, Leu134Pro in the KCNQ1 gene was not present in 200 control alleles from individuals of African American ancestry tested at GeneDx indicating it is likely not a common, benign variant in this population. The variant is found in LQT panel(s). -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at